Pharma & Biotech

Scientific instrument manufacturer Bruker finds itself at a critical juncture. Despite delivering a quarterly earnings surprise, the company's stock faced...

Biogen has secured two significant advancements that could reinvigorate the biotechnology company's growth trajectory. Recent developments include a streamlined treatment...

Investors in Bristol-Myers Squibb encountered a significant market downturn as the pharmaceutical giant and its collaborator, Johnson & Johnson, terminated...

Investor attention is firmly fixed on Arrowhead Pharmaceuticals this week as the biotechnology firm approaches two significant milestones that could...

Eli Lilly shares are positioned for a strong week following two significant developments from opposite sides of the Atlantic. The...

Redcare Pharmacy is making a decisive move to restore investor confidence by appointing a seasoned e-commerce executive as its new...

IO Biotech faces a pivotal moment in its corporate history as financial pressures mount and regulatory challenges intensify. The biotechnology...

MannKind Corporation finds itself at a critical juncture as conflicting signals emerge from its recent corporate developments. While the biopharmaceutical...

Vapotherm has achieved a significant regulatory milestone with the U.S. Department of Defense granting operational approval for its HVT® 2.0...

The curtain is closing on ViewRay as the company enters the final stage of its corporate existence. With the bankruptcy...